HIV Drugs Market in India 2010-2014

Date: November 1, 2011
Pages: 32
Price:
US$ 1,500.00
License [?]:
Publisher: Infiniti Research
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H02AF8B0102EN
Leaflet:

Download PDF Leaflet

HIV Drugs Market in India 2010-2014
TechNavio’s analysts forecast the HIV Drugs market in India to reach US$54 million by 2014. One of the key factors contributing to this market growth is the increasing prevalence of HIV in India and the longer life expectancy of HIV patients. The HIV Drugs market in India has also been witnessing the development of immune-based therapies for HIV. However, the inadequate availability of physicians with a specialization in HIV treatment could be a challenge to the growth of this market. TechNavio’s report, HIV Drugs Market in India 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on India and covers healthcare institutions, over the counter/retail, and HIV rehabilitation centers. The report analyzes the current HIV Drugs market landscape and its growth prospects. It also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market include Cipla Ltd., Hetero Drugs Ltd., Ranbaxy Laboratories Ltd., and Zydus Cadila Healthcare Ltd.

Key questions answered in this report:
  • What will the market size be in 2014 and at what rate will it grow?
  • What key trends is this market subject to?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?
1. EXECUTIVE SUMMARY

2. INTRODUCTION

3. MARKET COVERAGE

4. MARKET LANDSCAPE

5. VENDOR LANDSCAPE

6. BUYING CRITERIA

7. MARKET GROWTH DRIVERS

8. DRIVERS AND THEIR IMPACT

9. MARKET CHALLENGES

10. MARKET TRENDS

11. KEY VENDOR ANALYSIS

11.1 Cipla Limited
11.2 Hetero Drugs Ltd
11.3 Ranbaxy Laboratories Ltd.
11.4 Zydus Cadila Healthcare Ltd

12. OTHER REPORTS IN THIS SERIES

LIST OF EXHIBITS

Exhibit 1: HIV Drugs Market in India 2010–2014 (US$ million)
Exhibit 2: India HIV Drugs Market Segmentation by Geography – 2010
Exhibit 3: Split of Key Customer Segments in the HIV Drugs Market in India – 2010
Exhibit 4: Price Range of HIV Drugs for Treatments in India
Exhibit 5: Split of Modes of HIV Disease Transmissions in India
Exhibit 6: Split of Indian Companies and MNC on India HIV Drugs Market – 2010
Exhibit 7: HIV Drugs Market in India by Key Vendor Segmentation – 2010

Ask Your Question

HIV Drugs Market in India 2010-2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: